The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole - sprookjes - yvandenbroek - TriplyDB

The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole

The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole

http://www.wikidata.org/entity/Q37160745

about

Medical interventions for fungal keratitis Recent advances in diagnosis and management of Mycotic Keratitis Recent trends: Medical management of infectious keratitis Review of clinical and basic approaches of fungal keratitis Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.A rare pigmented keratitis caused by Aspergillus fumigatus.Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.First Human Case of Fungal Keratitis Caused by a Putatively Novel Species of Lophotrichus.Prospective Study of the Diagnostic Accuracy of the In Vivo Laser Scanning Confocal Microscope for Severe Microbial Keratitis.RelA-Mediated BECN1 Expression Is Required for Reactive Oxygen Species-Induced Autophagy in Oral Cancer Cells Exposed to Low-Power Laser Irradiation Treatment with intrastromal and intracameral voriconazole in 2 eyes with Lasiodiplodia theobromae keratitis: case reports.Rhizopus Keratitis Associated with Poor Contact Lens Hygiene Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial.Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.Neutrophil extracellular traps involvement in corneal fungal infection Altered Patterns of Fungal Keratitis at a London Ophthalmic Referral Hospital: An Eight-Year Retrospective Observational Study.In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.Corneal infections in the 21st century.Clinical and microbiological study of paediatric infectious keratitis in South India: a 3-year study (2011-2013).Fungal Keratitis Secondary to Trametes betulina: A Case Report and Review of Literature.Fusarium Keratitis in Germany.The diagnosis and management of contact lens-related microbial keratitis.The Utility of Repeat Culture in Fungal Corneal Ulcer Management: A Secondary Analysis of the MUTT-I Randomized Clinical Trial.Multidrug-resistant Fusarium keratitis: diagnosis and treatment considerations.Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.Contact-Lens-Associated Purpureocillium Keratitis: Risk Factors, Microbiologic Characteristics, Clinical Course, and Outcomes.Inhibitory effects of antimicrobial agents against Fusarium species.Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.Keratitis due to Fusarium langsethiae: clinical profile, molecular identification, and susceptibility to antifungals.Aspergillus flavus endophthalmitis after penetrating keratoplasty combined with cataract phacoemulsification and IOL implantation.Intrastromal voriconazole for deep recalcitrant fungal keratitis: a case series.Update on the Management of Infectious Keratitis.

P2860

Q24186589-8EAFCBDE-B0DE-4FC7-AD15-96E8F2F90070 Q26744422-7C7FB5AC-7711-4E6F-9A70-84DD11A87E84 Q26775838-1AA8FA33-51A4-4E74-8C7E-032CD0251280 Q28074867-46ACC929-DD0D-4FB3-BD7B-06C487FC7454 Q34005900-5A762CA7-C67B-497E-84C6-AC35949FDF59 Q34532546-130800E8-09C9-4778-9CBD-EF207551FAC9 Q35075428-12903E00-0A07-4496-85F7-B1848E703707 Q35691951-A31E56B2-C7B0-4F05-AB3A-A727B216B803 Q35878130-728607D9-DE92-4F6C-BA9C-D275EA6ECF43 Q35968696-331DD2BC-D96F-4239-B36B-4A2CA981DC8F Q36107451-EC4FD0FD-084D-4481-A1A8-568E65710B44 Q36134661-6F3838CA-C1C1-4F43-98A5-7E8C2214AB13 Q36152402-B87A7CF0-CADE-4714-8B5D-3F6B01006B29 Q36566529-E5E83D46-0BE8-42AE-8771-0ADEF999CD29 Q36933883-9EBC4C1B-D960-4470-AD4A-D0EA6DFA782D Q37130051-8A099FF6-4356-4ABF-B12A-1F1BBBA13AE0 Q37130062-2D926C5A-0CA1-462D-8B94-30B2854BEA25 Q37130503-A9B45D7C-097F-4BD4-9F1E-2F000AA1FF5A Q37136368-1B155E0E-B13D-44E6-8267-3F4AE8762B07 Q37149203-AE86A0DA-B470-475E-9799-827D361D7FC5 Q37158706-30359319-A66B-41E7-82FC-61EAE959EA42 Q37497644-73D7600B-AF82-4782-99CD-838FBDD8635E Q38377743-49CBC891-C323-4497-B7AB-0D5596CBCD7B Q38385726-219C8BFA-7946-4E98-8931-3B51D793DF96 Q38583710-DA38046E-53AA-4F83-AC40-78C9E144E4B4 Q38751067-FBC1D689-A480-4F58-A6B2-48BCE058CDE0 Q39190561-B955CA30-8639-43AB-B19C-BA3239D219DA Q39571535-3A30E4D8-E611-4E55-B7A9-24F248EDAD40 Q40090439-6FDC8EEA-C648-46CC-B138-FE7DE91B3198 Q40254309-B018DA6F-0CEE-4163-835C-97906BDC849A Q40589234-784E8538-6FDB-476E-9556-69957FA1D0FD Q40669146-135F80E6-2205-433D-B3CB-331A79F646E3 Q41055790-9C6E718A-8E15-4D89-99BC-99217059828F Q41340089-32404D3C-07C2-473D-8F20-00F15EBDDAFD Q41357063-A500C632-42E8-498D-A4A1-5CA42AF52F09 Q41449739-022C9BE4-5A13-45EF-988F-D836C446BE30 Q41489648-37CA1674-8B3B-4E83-A403-D4512B534EE4 Q41609918-417C706A-3F04-4F2A-9DC8-4715561F0C48 Q41756142-EB07B62B-A479-4A51-88CB-F89D99CF3189 Q41931288-41002855-428E-4A0C-81BA-446264F56AB9

P2860

The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole

http://www.wikidata.org/entity/Q37160745

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole

@en

The mycotic ulcer treatment tr ...... ing natamycin vs voriconazole.

@nl

type

label

The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole

@en

The mycotic ulcer treatment tr ...... ing natamycin vs voriconazole.

@nl

prefLabel

The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole

@en

The mycotic ulcer treatment tr ...... ing natamycin vs voriconazole.

@nl

P1433

Q37160745-63FC529E-9420-4F4D-96DC-CE437ECA9B94

P1476

Q37160745-494A8BEF-1BC9-4358-A8B2-E35389C9B9D4

P2093

Q37160745-12D1DC40-A553-4454-B657-A7A261E2ED46

Q37160745-1776D77F-3F9E-4DF1-9CD4-560D54424886

Q37160745-1C1036F6-8CEC-4AE6-A3E0-8C81FD58EB5E

Q37160745-32A8B164-2C7F-49AD-AAF6-2BFF0C68A92C

Q37160745-6C7F5F0D-BC43-4281-9F73-D07D292E8FC0

Q37160745-6CEC2920-0BF8-4A91-8649-3E9B4AB4189B

Q37160745-7B35E414-35A7-4D95-B29E-95E03F518F22

Q37160745-7E4046CF-D63C-4CDC-96B8-2C213A574DFD

Q37160745-9305EC3B-03B9-4DA0-A80B-0454FEB64793

Q37160745-DBBFED3E-B855-470C-8423-198AB97CEE9A

P2860

Q37160745-0DD03B8A-1BE1-4F42-AF17-372646A809BE

Q37160745-1AE4AF5C-0EAB-416A-AB9C-1821A42E8410

Q37160745-1D5CB3B3-2ECB-4918-A210-D36D234CA5D1

Q37160745-24800127-519B-4EA6-8E2D-938ED4E1BEDE

Q37160745-3FC286A4-695B-4644-8D58-46C9F3614A23

Q37160745-482951E7-5A2F-4947-9E2F-1FC45CDFB279

Q37160745-67F3D1E7-120A-4117-A8BD-57CEFA0AF6DF

Q37160745-78BDD02D-F86C-4A1E-B7C3-DBE07B0BC990

Q37160745-78FE07A6-CA72-47DE-98A1-3001270D0BC8

Q37160745-7DA546AC-8D59-4302-9949-F8C976407E1A

P304

Q37160745-A2071F97-CF8B-435E-A029-E3D5FE14F40B

P31

Q37160745-E7CB61CF-949E-4927-BBFA-D74A79EE03B7

P356

Q37160745-3D485BCF-F721-4BDC-A796-381293F8961B

P407

Q37160745-FD237ECC-AEC7-465B-AC0E-8EB1BF4AC695

P433

Q37160745-51995CE5-C036-4344-97D3-CD566399062B

P478

Q37160745-3E3AD69B-C4EF-4009-A046-8006440DF9AC

P50

Q37160745-59A2D140-3BE8-4D6A-A39C-63A84A155130

Q37160745-9B64A8B3-D125-4014-B939-DDE162F4ED65

Q37160745-C2B69D87-1058-4FFC-B0CE-0AE60096E8A6

P577

Q37160745-EDA57B48-F027-4C98-8600-1A9BE1B19247

P698

Q37160745-7E62DA07-2E57-4B41-8087-6221C8F478B2

P932

Q37160745-A1B6CFFB-7C92-45CF-A71E-D674A40608FE

P356

JAMAOPHTHALMOL.2013.1497

P1433

JAMA Ophthalmology

P1476

The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole

@en

P2093

Anita Raghavan

http://www.w3.org/2001/XMLSchema#string

Jeena Mascarenhas

http://www.w3.org/2001/XMLSchema#string

Kathryn J Ray

http://www.w3.org/2001/XMLSchema#string

Lalitha Prajna

http://www.w3.org/2001/XMLSchema#string

Michael E Zegans

http://www.w3.org/2001/XMLSchema#string

Muthiah Srinivasan

http://www.w3.org/2001/XMLSchema#string

Mycotic Ulcer Treatment Trial Group

http://www.w3.org/2001/XMLSchema#string

N Venkatesh Prajna

http://www.w3.org/2001/XMLSchema#string

Nisha R Acharya

http://www.w3.org/2001/XMLSchema#string

Revathi Rajaraman

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India

A new method to predict the epidemiology of fungal keratitis by monitoring the sales distribution of antifungal eye drops in Brazil

Corneal blindness: a global perspective

The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.

Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh

Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature.

Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.

Comparison of natamycin and voriconazole for the treatment of fungal keratitis.

Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).

Trends in fungal keratitis in the United States, 2001 to 2007.

P304

422-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAOPHTHALMOL.2013.1497

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

Thomas M Lietman

Catherine E Oldenburg

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23710492

http://www.w3.org/2001/XMLSchema#string

P932

3769211

http://www.w3.org/2001/XMLSchema#string